BK virus-specific immunity kinetics: A predictor of recovery from polyomavirus BK-associated nephropathy

American Journal of Transplantation

Volumn 11, Issue 11, 2011, Pages 2443-2452

  Schachtner, T ^a   Mu ller K ^a   Stein, M ^a   Diezemann, C ^a   Sefrin, A ^a   Babel, N ^a,b   Reinke, P ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Berlin Brandenburg Center of Regenerative Therapies (BCRT)   (Germany)

Author keywords

BKV associated nephropathy; ELISA; ELISPOT assay; Polyomavirus BK

Indexed keywords

AZATHIOPRINE; CIDOFOVIR; CYCLOSPORIN A; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; RAPAMYCIN; T LYMPHOCYTE ANTIGEN; TACROLIMUS; VIRUS PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BK VIRUS; BK VIRUS ASSOCIATED NEPHROPATHY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; MALE; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RNA VIRUS INFECTION; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS REACTIVATION;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL, TUMOR; BK VIRUS; FEMALE; HUMANS; IMMUNITY, CELLULAR; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS; VIRUS ACTIVATION;

EID: 84857195784     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03693.x     Document Type: Article

References (31)

1. Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirusassociated nephropathy: Update on BK virus-specific immunity. Transpl Infect Dis 2006; 8: 86-94. (Pubitemid 43829485)
2. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-1089. (Pubitemid 29203096)
3. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151. (Pubitemid 34790793)
4. Babel N, Fendt J, Karaivanov S, et al. BK viruria as an early marker for the development of BKV-associated nephropathy: Analysis of 4128 urine and serum samples. Transplantation 2009; 88: 89-95.
5. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315. (Pubitemid 30408715)
6. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renaltransplant recipients. N Engl J Med 2002; 347: 488-496. (Pubitemid 34879336)
7. Bennett WM, Meyer L, Ridenour J, Batiuk TD. Surveillance and modification of immunosuppression minimizes BK virus nephropathy. Am J Nephrol 2010; 32: 10-12.
8. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirusassociated nephropathy (PVAN). Am J Transplant 2006; 6(5 Pt 1): 1025-1032. (Pubitemid 44356654)
9. Brennan DC, Agha I, Bohl DL, et al. Incidence of BKwith tacrolimus versus cyclosporine and impact of preemptive immunosuppression reducation. Am J Transplant 2005; 5: 582-594. (Pubitemid 40313351)
10. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611-623. (Pubitemid 37210225)
11. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109. (Pubitemid 29061146)
12. Trofe JT, Cavallo MR, First P, et al. Polyomavirus nephropathy in kidney transplantation. Prog Transplant 2002; 14: 130-140.
13. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: Morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 2003; 12: 599-605. (Pubitemid 38186750)
14. Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol 2010; 47: 306-312.
15. Imperiale MJ. The human polyomaviruses: An overview. In: Khalili K, Stoner GL eds. Human polyomaviruses: Molecular and clinical perspectives. New York: Wiley-Liss, 2001, 53-71.
16. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007; 2: 36-46.
17. Cai X, Chang D, Rottinghaus S, Consigli RA. Expression and purification of recombinant polyomavirus VP2 protein and its interactions with polyomavirus proteins. J Virol 1994; 68: 7609-7613. (Pubitemid 24328824)
18. Müller K, Schachtner T, Sattler A, et al. BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation 2011; 91: 100-107.
19. Binggeli S, Egli A, Dickenmann M, Binet I, Steiger J, Hirsch HH. BKV replication and cellular immune responses in renal transplant recipients. Am J Transplant 2006; 6: 2218-2219. (Pubitemid 44199559)
20. Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirusassociated nephropathy: Update on BK virus-specific immunity. Transpl Infect Dis 2006; 8: 86-94. (Pubitemid 43829485)
21. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of preemptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7: 2727-2735. (Pubitemid 350045762)
22. Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S. Recovery of BK virus Large T-antigen-specific cellular immune response correlates with resolution of BK virus nephritis. Transplantation 2008; 85: 185-192. (Pubitemid 351156848)
23. Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008; 13: 569-574.
24. Hirsch HH, Randhawa P, and the AST Infectious Diseases Community of Practice. BK virus in solid organ transplant recipients. Am J Transplantation 2009: 9(Suppl 4): 136-146.
25. Hammer MH, Brestrich G, Andree H, et al. HLA type-independent method to monitor polyoma BK virus-specific CD4+ and CD8+ T-cell immunity. Am J Transplantation 2006; 6: 625-631. (Pubitemid 43382152)
26. Comoli P, Basso S, Azzi A, et al. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol 2003; 14: 3197-3204. (Pubitemid 37509295)
27. Alméras C, Foulongne V, Garrigue V, et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 2008; 85: 1099-1104. (Pubitemid 351590186)
28. Hirsch HH. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354-360. (Pubitemid 41022114)
29. Bodaghi S, Comoli P, Bösch R, et al. Antibody response to recombinant polyomavirus BK Large T and VP1 proteins in young kidney transplant patients. J Clin Microbiol 2009; 47: 2577-2585.
30. Bohl DL, Brennan DC, Ryschkewitsch C, Gaudreault-Keener M, Major EO, Storch GA. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Vir 2007; 43: 184-189.
31. Hariharan S, Cohen EP, Brahm V, Orentas R, Viscidi RP. BK virusspecific antibodies and BKV DNA in renal transplant recipientswith BKV nephritis. Am J Transplant 2005; 5: 2719-2724.